Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication

Shin On Kang, Seung Ju Kim, Sohee Park, Sung In Jang, Euncheol Park

Research output: Contribution to journalArticle

Abstract

Objective We evaluate the effects of drug price reduction policy on pharmaceutical expenditure and prescription patterns in diabetes medication. Design An interrupted time series study design using generalized estimating equations. Setting This study used National Health Insurance claim data from 2010 to 2013. Participants A total of 68 127 diabetes patients and 12 465 hospitals. Intervention(s) The drug price reduction policy. Main Outcome Measures The primary outcome is pharmaceutical expenditure and prescription rate. To evaluate changes in prescription rate, we measured prescription rates such a brand-name drug and drug price reduction rate. Results Although the drug price reduction policy associated with decreased pharmaceutical expenditure (-13.22%, P < 0.0001), the trend (-0.01%, P = 0.9201) did not change significantly compared with the pre-intervention period. In addition, the trends in the monthly prescription rate of brand-name drugs decreased (-0.14%, P = 0.0091), while the immediate change was an increase (5.72%, P < 0.0001). Regardless of the drug reduction rate, the prescription rate after the introduction of the drug price reduction policy decreased compared with the pre-intervention period, and this decline was significant for reduction rates of 0% (-2.74%, P < 0.0001) and 10% (-0.13%, P = 0.0018). Conclusions Our results provide evidence of the effects of the drug price reduction policy on pharmaceutical expenditure and prescription patterns. This policy did not affect the prescribing behavior of healthcare providers and did not increase the use of drugs not subject to this policy. Although this study did not observe changes in the cost of pharmaceuticals after the introduction of the drug price reduction policy, further research is needed on the long-Term changes in such costs.

Original languageEnglish
Pages (from-to)96-102
Number of pages7
JournalInternational Journal for Quality in Health Care
Volume31
Issue number2
DOIs
Publication statusPublished - 2019 Mar 1

Fingerprint

Republic of Korea
Cost Control
Physicians
Pharmaceutical Preparations
Prescriptions
Health Expenditures
Drug and Narcotic Control
Names
Costs and Cost Analysis
National Health Programs
Health Personnel

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

@article{49fda68558274434a9120405992692e7,
title = "Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication",
abstract = "Objective We evaluate the effects of drug price reduction policy on pharmaceutical expenditure and prescription patterns in diabetes medication. Design An interrupted time series study design using generalized estimating equations. Setting This study used National Health Insurance claim data from 2010 to 2013. Participants A total of 68 127 diabetes patients and 12 465 hospitals. Intervention(s) The drug price reduction policy. Main Outcome Measures The primary outcome is pharmaceutical expenditure and prescription rate. To evaluate changes in prescription rate, we measured prescription rates such a brand-name drug and drug price reduction rate. Results Although the drug price reduction policy associated with decreased pharmaceutical expenditure (-13.22{\%}, P < 0.0001), the trend (-0.01{\%}, P = 0.9201) did not change significantly compared with the pre-intervention period. In addition, the trends in the monthly prescription rate of brand-name drugs decreased (-0.14{\%}, P = 0.0091), while the immediate change was an increase (5.72{\%}, P < 0.0001). Regardless of the drug reduction rate, the prescription rate after the introduction of the drug price reduction policy decreased compared with the pre-intervention period, and this decline was significant for reduction rates of 0{\%} (-2.74{\%}, P < 0.0001) and 10{\%} (-0.13{\%}, P = 0.0018). Conclusions Our results provide evidence of the effects of the drug price reduction policy on pharmaceutical expenditure and prescription patterns. This policy did not affect the prescribing behavior of healthcare providers and did not increase the use of drugs not subject to this policy. Although this study did not observe changes in the cost of pharmaceuticals after the introduction of the drug price reduction policy, further research is needed on the long-Term changes in such costs.",
author = "Kang, {Shin On} and Kim, {Seung Ju} and Sohee Park and Jang, {Sung In} and Euncheol Park",
year = "2019",
month = "3",
day = "1",
doi = "10.1093/intqhc/mzy114",
language = "English",
volume = "31",
pages = "96--102",
journal = "International Journal for Quality in Health Care",
issn = "1353-4505",
publisher = "Oxford University Press",
number = "2",

}

Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication. / Kang, Shin On; Kim, Seung Ju; Park, Sohee; Jang, Sung In; Park, Euncheol.

In: International Journal for Quality in Health Care, Vol. 31, No. 2, 01.03.2019, p. 96-102.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication

AU - Kang, Shin On

AU - Kim, Seung Ju

AU - Park, Sohee

AU - Jang, Sung In

AU - Park, Euncheol

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Objective We evaluate the effects of drug price reduction policy on pharmaceutical expenditure and prescription patterns in diabetes medication. Design An interrupted time series study design using generalized estimating equations. Setting This study used National Health Insurance claim data from 2010 to 2013. Participants A total of 68 127 diabetes patients and 12 465 hospitals. Intervention(s) The drug price reduction policy. Main Outcome Measures The primary outcome is pharmaceutical expenditure and prescription rate. To evaluate changes in prescription rate, we measured prescription rates such a brand-name drug and drug price reduction rate. Results Although the drug price reduction policy associated with decreased pharmaceutical expenditure (-13.22%, P < 0.0001), the trend (-0.01%, P = 0.9201) did not change significantly compared with the pre-intervention period. In addition, the trends in the monthly prescription rate of brand-name drugs decreased (-0.14%, P = 0.0091), while the immediate change was an increase (5.72%, P < 0.0001). Regardless of the drug reduction rate, the prescription rate after the introduction of the drug price reduction policy decreased compared with the pre-intervention period, and this decline was significant for reduction rates of 0% (-2.74%, P < 0.0001) and 10% (-0.13%, P = 0.0018). Conclusions Our results provide evidence of the effects of the drug price reduction policy on pharmaceutical expenditure and prescription patterns. This policy did not affect the prescribing behavior of healthcare providers and did not increase the use of drugs not subject to this policy. Although this study did not observe changes in the cost of pharmaceuticals after the introduction of the drug price reduction policy, further research is needed on the long-Term changes in such costs.

AB - Objective We evaluate the effects of drug price reduction policy on pharmaceutical expenditure and prescription patterns in diabetes medication. Design An interrupted time series study design using generalized estimating equations. Setting This study used National Health Insurance claim data from 2010 to 2013. Participants A total of 68 127 diabetes patients and 12 465 hospitals. Intervention(s) The drug price reduction policy. Main Outcome Measures The primary outcome is pharmaceutical expenditure and prescription rate. To evaluate changes in prescription rate, we measured prescription rates such a brand-name drug and drug price reduction rate. Results Although the drug price reduction policy associated with decreased pharmaceutical expenditure (-13.22%, P < 0.0001), the trend (-0.01%, P = 0.9201) did not change significantly compared with the pre-intervention period. In addition, the trends in the monthly prescription rate of brand-name drugs decreased (-0.14%, P = 0.0091), while the immediate change was an increase (5.72%, P < 0.0001). Regardless of the drug reduction rate, the prescription rate after the introduction of the drug price reduction policy decreased compared with the pre-intervention period, and this decline was significant for reduction rates of 0% (-2.74%, P < 0.0001) and 10% (-0.13%, P = 0.0018). Conclusions Our results provide evidence of the effects of the drug price reduction policy on pharmaceutical expenditure and prescription patterns. This policy did not affect the prescribing behavior of healthcare providers and did not increase the use of drugs not subject to this policy. Although this study did not observe changes in the cost of pharmaceuticals after the introduction of the drug price reduction policy, further research is needed on the long-Term changes in such costs.

UR - http://www.scopus.com/inward/record.url?scp=85062985284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062985284&partnerID=8YFLogxK

U2 - 10.1093/intqhc/mzy114

DO - 10.1093/intqhc/mzy114

M3 - Article

C2 - 29788203

AN - SCOPUS:85062985284

VL - 31

SP - 96

EP - 102

JO - International Journal for Quality in Health Care

JF - International Journal for Quality in Health Care

SN - 1353-4505

IS - 2

ER -